Lupin receives nine observations from USFDA for Goa plant
Drug major Lupin on Tuesday says that it has received nine observations relating to inadequacy and adherence to operating norms for its manufacturing plant in Goa from the US Food and Drug Administration (USFDA)
Mar 15, 2016, 18:09 PM IST